Are you a Health Professional? Jump over to the doctors only platform. Click Here

Archive

New recommendations on genetic testing for women with ovarian cancer

A new position statement from Cancer Australia recommends that all women diagnosed with invasive epithelial ovarian cancer be offered the […]

Hormone treatment for breast cancer linked to chronic disease later in life

Women who receive hormonal therapy for breast cancer are at increased risk of developing chronic conditions later in life, according […]

New blood test that screens for eight common cancers

Researchers at the Johns Hopkins Kimmel Cancer Center have developed a single blood test that screens for eight common cancer types and […]

Key protein stops breast cancer spread

A discovery by La Trobe University breast cancer researchers could spare some women from having unnecessary treatment. Researchers from the […]

Huge health benefits by cutting back sugar in sugary drinks

More than 150,000 Australian deaths could be prevented if the energy content of sugary drinks was cut by around a […]

MSAC supports the MBS listing of genetic testing for hereditary mutations for b…

Following the Royal College of Pathologists of Australasia’s (RCPA) application to the Medical Services Advisory Committee (MSAC), it is pleased to announce […]

Standard care for breast cancer trials not always standard

New research has found that some breast cancer trials are failing to provide appropriate control group treatments, affecting the outcomes […]

Protein to control breast cancer progression identified

Switching off a protein produced in breast cancer cells can stop cancer progression, researchers from The University of Queensland have […]

Textured Breast implants pose the greatest risk of implant-associated cancer

Researchers at Macquarie University’s MQ Health have revealed that women implanted with textured breast implants are at a significantly higher […]

One in five breast cancer patients could benefit from BRCA treatments

More breast cancer patients could benefit from treatments currently used only for patients with a faulty BRCA1 or BRCA2 gene, […]